Exercise Tied to Lower Mortality With Dementia
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- Maintaining or initiating regular physical activity (PA) after a dementia diagnosis is associated with a reduced risk for all-cause mortality, according to a study published online Oct. 29 in the British Journal of Sports Medicine.
Kye-Yeung Park, from the Hanyang University College of Medicine in Seoul, South Korea, and colleagues examined associations between the amount and changes in regular PA before and after a diagnosis of dementia and all-cause mortality risk and whether these associations differ by PA intensity (light, moderate, or vigorous). The analysis included data from 60,252 individuals newly diagnosed with dementia (2010 to 2016) followed for a mean 3.7 years.
The researchers found that higher PA levels after dementia diagnosis were associated with a dose-dependent decrease in mortality risk. Compared with remaining inactive, maintaining regular PA was associated with the lowest mortality risk (hazard ratio [HR], 0.71). This decrease in mortality risk with sustained engagement in PA persisted across intensities (light: HR, 0.70; moderate: HR, 0.74; and vigorous PA: HR, 0.70). There was a 20 percent reduction in mortality risk with initiating any PA intensity after a dementia diagnosis. Associations remained in Alzheimer disease.
"Lifestyle modifications promoting PA might offer survival benefits for individuals with dementia," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.